Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	dendritic spine	NCOA2 CTTNBP2 SYNE1 CPEB4 PRKAR2B NOS1	1.60e-04	242	70	6	GO:0043197
GeneOntologyCellularComponent	neuron spine	NCOA2 CTTNBP2 SYNE1 CPEB4 PRKAR2B NOS1	1.78e-04	247	70	6	GO:0044309
MousePheno	decreased fetal size	CITED2 ATP23 LPAR4 COL27A1 VCAN LGR4 PLXND1 SCRIB	6.40e-06	229	61	8	MP:0004200
MousePheno	abnormal fetal size	CITED2 ATP23 LPAR4 COL27A1 VCAN LGR4 PLXND1 SCRIB	8.23e-06	237	61	8	MP:0004198
MousePheno	abnormal chondrocyte physiology	COL27A1 PKD1 EDIL3 TNS3	3.24e-05	42	61	4	MP:0009780
MousePheno	abnormal cartilage physiology	COL27A1 PKD1 EDIL3 TNS3	3.57e-05	43	61	4	MP:0031306
MousePheno	abnormal fetal growth/weight/body size	CITED2 ATP23 LPAR4 COL27A1 VCAN LGR4 PLXND1 SCRIB	5.93e-05	312	61	8	MP:0004197
MousePheno	prenatal lethality, incomplete penetrance	CITED2 LPAR4 SLC2A9 BRCA1 BRAF VCAN PKD1 LGR4 NCF4 PLXND1 SCRIB PGAP6	7.69e-05	747	61	12	MP:0011101
Domain	CHDCT2	CHD3 CHD4	4.26e-05	3	71	2	PF08074
Domain	CHDNT	CHD3 CHD4	4.26e-05	3	71	2	PF08073
Domain	DUF1086	CHD3 CHD4	4.26e-05	3	71	2	IPR009462
Domain	DUF1087	CHD3 CHD4	4.26e-05	3	71	2	IPR009463
Domain	CHD_N	CHD3 CHD4	4.26e-05	3	71	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	4.26e-05	3	71	2	IPR012957
Domain	DUF1087	CHD3 CHD4	4.26e-05	3	71	2	PF06465
Domain	DUF1086	CHD3 CHD4	4.26e-05	3	71	2	PF06461
Domain	DUF1087	CHD3 CHD4	4.26e-05	3	71	2	SM01147
Domain	DUF1086	CHD3 CHD4	4.26e-05	3	71	2	SM01146
Domain	EGF_3	FAT1 VCAN TEK EDIL3 PGAP6	2.00e-03	235	71	5	PS50026
Domain	EGF	FAT1 VCAN TEK EDIL3 PGAP6	2.00e-03	235	71	5	SM00181
Domain	EGF-like_dom	FAT1 VCAN TEK EDIL3 PGAP6	2.58e-03	249	71	5	IPR000742
Domain	EGF_1	FAT1 VCAN TEK EDIL3 PGAP6	2.85e-03	255	71	5	PS00022
Domain	EGF-like_CS	FAT1 VCAN TEK EDIL3 PGAP6	3.15e-03	261	71	5	IPR013032
Domain	EGF_2	FAT1 VCAN TEK EDIL3 PGAP6	3.36e-03	265	71	5	PS01186
Domain	Chromo_domain	CHD3 CHD4	3.73e-03	24	71	2	IPR023780
Domain	LRR_8	PKD1 LGR4 SCRIB SLITRK1	4.09e-03	171	71	4	PF13855
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4 EDIL3	8.51e-09	3	72	3	32658897
Pubmed	Tie2 regulates endocardial sprouting and myocardial trabeculation.	CYP1B1 AFP VCAN PLXND1 TEK	3.11e-07	68	72	5	31112136
Pubmed	Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation.	FAT1 MIP SCRIB	1.39e-06	11	72	3	26114487
Pubmed	The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.	NCOA2 PRR12 HOXC10 AGFG1	1.96e-06	43	72	4	26487511
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	BRCA1 CHD3 CHD4	2.40e-06	13	72	3	19703393
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 PRR12 BRCA1 AP1B1 XPO5 NAE1 PYGL MCM7 CHD3 CHD4 RRM1 INO80D	2.60e-06	1103	72	12	34189442
Pubmed	NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.	BRCA1 CHD3 CHD4	3.05e-06	14	72	3	25150861
Pubmed	Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis.	PLXND1 TEK EDIL3	3.80e-06	15	72	3	24043815
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	4.23e-06	2	72	2	7560064
Pubmed	BRCA1 protein dose-dependent risk for embryonic oxidative DNA damage, embryopathies and neurodevelopmental disorders with and without ethanol exposure.	BRCA1 EDIL3	4.23e-06	2	72	2	38359745
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	4.23e-06	2	72	2	7575689
Pubmed	Breast cancer 1 (BRCA1)-deficient embryos develop normally but are more susceptible to ethanol-initiated DNA damage and embryopathies.	BRCA1 EDIL3	4.23e-06	2	72	2	26629949
Pubmed	Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.	SLC2A9 PKD1	4.23e-06	2	72	2	32166738
Pubmed	Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma.	CYP1B1 TEK	4.23e-06	2	72	2	28620713
Pubmed	Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer.	BRCA1 RRM1	4.23e-06	2	72	2	25078585
Pubmed	Aldosterone-induced ENaC and basal Na+/K+-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells.	PI4KB PKD1	4.23e-06	2	72	2	23541637
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	4.23e-06	2	72	2	35568926
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	4.23e-06	2	72	2	8843877
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	GPC1 CYP1B1 FAT1 MAN2B1 NAE1 LGR4 ALG11 PLXND1 SCRIB RRM1 PPP6R2 EDIL3	6.18e-06	1201	72	12	35696571
Pubmed	Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.	DNAJC13 CRACR2A AP1B1 SYNE1 PI4KB AGFG1 SCRIB	6.72e-06	339	72	7	37232246
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PRR12 CTTNBP2 COL27A1 CPEB4 KCNS2 PPP6R2 SLITRK1 MAST3	8.33e-06	493	72	8	15368895
Pubmed	The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes.	BRCA1 RRM1	1.27e-05	3	72	2	21394302
Pubmed	ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.	BRCA1 RRM1	1.27e-05	3	72	2	20467918
Pubmed	Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.	BRCA1 RRM1	1.27e-05	3	72	2	19002265
Pubmed	Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.	BRCA1 RRM1	1.27e-05	3	72	2	23155271
Pubmed	Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.	BRAF EDIL3	1.27e-05	3	72	2	26657898
Pubmed	Primary Congenital Glaucoma	CYP1B1 TEK	1.27e-05	3	72	2	20301314
Pubmed	mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.	BRCA1 RRM1	1.27e-05	3	72	2	23803067
Pubmed	A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.	DLC1 TNS3	1.27e-05	3	72	2	26166433
Pubmed	Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.	NCOA2 BRCA1	1.27e-05	3	72	2	11085509
Pubmed	Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.	BRCA1 BRAF	1.27e-05	3	72	2	35567913
Pubmed	Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2.	DLC1 AFP EDIL3	2.14e-05	26	72	3	28193997
Pubmed	[Analysis of polymorphisms in genes of insulin receptor substrate-1 and enzymes involved in estrogen biosynthesis and metabolism among breast cancer patients with BRCA1 mutations].	CYP1B1 BRCA1	2.53e-05	4	72	2	19514368
Pubmed	NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.	CHD3 CHD4	2.53e-05	4	72	2	16574654
Pubmed	Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.	BRCA1 RRM1	2.53e-05	4	72	2	26542178
Pubmed	Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.	RCAN1 EDIL3	2.53e-05	4	72	2	21947295
Pubmed	Characterization of the CHD family of proteins.	CHD3 CHD4	2.53e-05	4	72	2	9326634
Pubmed	Characterization of the murine Inpp4b gene and identification of a novel isoform.	MAN2B1 USP38	2.53e-05	4	72	2	16631325
Pubmed	The Cardiac TBX5 Interactome Reveals a Chromatin Remodeling Network Essential for Cardiac Septation.	CHD4 EDIL3	2.53e-05	4	72	2	26859351
Pubmed	Defective development of the gall bladder and cystic duct in Lgr4- hypomorphic mice.	AFP LGR4	2.53e-05	4	72	2	19301403
Pubmed	Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy.	BRCA1 RRM1	2.53e-05	4	72	2	25227663
Pubmed	Genetic link between renal birth defects and congenital heart disease.	AP1B1 PKD1 PLXND1	2.69e-05	28	72	3	27002738
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 DNAJC13 CTTNBP2 AP1B1 SYNE1 PRKAR2B CHD4 SCRIB PPP6R2 NOS1	2.87e-05	963	72	10	28671696
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT1 DNAJC13 BRCA1 PI4KB LGR4 MCM7 CHD4 PLXND1 SCRIB	3.21e-05	777	72	9	35844135
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPC1 DNAJC13 CTTNBP2 AP1B1 SYNE1 VCAN CPEB4 PRKAR2B CHD3 SCRIB PPP6R2 NOS1	3.51e-05	1431	72	12	37142655
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	DNAJC13 AGFG1 MCM7 RPRD2 CHD3 CHD4	3.66e-05	298	72	6	30737378
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CTTNBP2 BRAF AP1B1 ZFP36L2 PI4KB CPEB4 PPP6R2	3.91e-05	446	72	7	24255178
Pubmed	The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.	DLC1 TNS3	4.21e-05	5	72	2	17190795
Pubmed	Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.	BRAF TEK	4.21e-05	5	72	2	26285778
Pubmed	Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency.	CITED2 EDIL3	4.21e-05	5	72	2	18440989
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	DNAJC13 AP1B1 COQ8A XPO5 MCM7 CHD4 SCRIB RRM1	5.23e-05	638	72	8	33239621
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	HOXC10 SYNE1 NAE1 COL27A1 GAS2 CHD4	5.52e-05	321	72	6	32098917
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	AP1B1 PKD1 PLXND1 ICA1L	5.70e-05	100	72	4	25807483
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CTTNBP2 DLC1 SYNE1 CPEB4	6.15e-05	102	72	4	11214970
Pubmed	Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis.	AFP EDIL3	6.31e-05	6	72	2	18816823
Pubmed	The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.	DLC1 TNS3	6.31e-05	6	72	2	19732724
Pubmed	Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity.	CHD3 CHD4	6.31e-05	6	72	2	17626165
Pubmed	Identification of sperm-specific proteins that interact with A-kinase anchoring proteins in a manner similar to the type II regulatory subunit of PKA.	AKAP3 PRKAR2B	6.31e-05	6	72	2	11278869
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	DNAJC13 LGR4 CHD3 CHD4 SCRIB	6.42e-05	202	72	5	24639526
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FAT1 MCM7 CHD3 CHD4 SCRIB TNS3	6.65e-05	332	72	6	37433992
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	XPO5 MRPS23 AGFG1 MCM7 CHD4 SCRIB HNRNPH3	7.15e-05	491	72	7	22623428
Pubmed	PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex.	CHD3 CHD4 HNRNPH3	8.57e-05	41	72	3	22720776
Pubmed	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	AP1B1 RYR3	8.82e-05	7	72	2	20009918
Pubmed	BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.	NCOA2 BRCA1	8.82e-05	7	72	2	16860316
Pubmed	Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression.	BRCA1 CHD4	8.82e-05	7	72	2	23011797
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	DHRS12 BRAF AP1B1 RCAN1 PRKAR2B CHD4 PPP6R2 TNS3 MAST3	1.08e-04	910	72	9	36736316
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	DNAJC13 AP1B1 NAE1 MRPS23 PYGL MCM7 CHD4 SCRIB RRM1 HNRNPH3 TNS3	1.11e-04	1367	72	11	32687490
Pubmed	Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice.	BRAF PPIP5K1 NOS1	1.13e-04	45	72	3	28973166
Pubmed	Mammalian chromodomain proteins: their role in genome organisation and expression.	CHD3 CHD4	1.17e-04	8	72	2	10655032
Pubmed	Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology.	CYP1B1 BRCA1	1.17e-04	8	72	2	18415014
Pubmed	Overexpression of the Del1 gene causes dendritic branching in the mouse mesentery.	TEK EDIL3	1.17e-04	8	72	2	16302230
Pubmed	Cancer of mice and men: old twists and new tails.	BRCA1 BRAF	1.51e-04	9	72	2	23436574
Pubmed	Fli1 Promotes Vascular Morphogenesis by Regulating Endothelial Potential of Multipotent Myogenic Progenitors.	HOXC10 TEK	1.51e-04	9	72	2	34544261
Pubmed	A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.	AFP PPIP5K1	1.51e-04	9	72	2	23300138
Pubmed	Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.	BRCA1 BRAF	1.51e-04	9	72	2	30905671
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	GPC1 BRCA1 XPO5 COL27A1 CHD3	1.74e-04	250	72	5	33536335
Pubmed	Probing chromatin landscape reveals roles of endocardial TBX20 in septation.	VCAN TEK	1.88e-04	10	72	2	27348591
Pubmed	Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.	BRAF SCRIB	1.88e-04	10	72	2	23610450
Pubmed	The endoderm of the mouse embryo arises by dynamic widespread intercalation of embryonic and extraembryonic lineages.	AFP EDIL3	1.88e-04	10	72	2	18854136
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	CTTNBP2 BRCA1 USP38 AFP NAE1 PYGL CHD4 SCRIB PPP6R2	2.26e-04	1005	72	9	19615732
Pubmed	Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation.	AFP NOS1	2.30e-04	11	72	2	9802886
Pubmed	Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1.	VCAN CHD4	2.30e-04	11	72	2	37254794
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	CHD3 CHD4	2.30e-04	11	72	2	10204490
Pubmed	An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.	MCM7 RRM1	2.30e-04	11	72	2	31693903
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	PRR12 DNAJC13 UBQLN4 MCM7 CHD3 CHD4	2.33e-04	418	72	6	34709266
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 PRR12 RPRD2 CHD3 CHD4	2.40e-04	268	72	5	33640491
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	GPC1 DNAJC13 SYNE1 MCM7 CHD4 PPP6R2 EDIL3 HNRNPH3	2.54e-04	803	72	8	36517590
Pubmed	Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.	BRCA1 PI4KB COL27A1 SCRIB	2.59e-04	148	72	4	22898364
Pubmed	NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.	CHD3 CHD4	2.75e-04	12	72	2	9885572
Pubmed	Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes.	NCF4 NOS1	2.75e-04	12	72	2	19283362
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	CHD3 CHD4	2.75e-04	12	72	2	22560079
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PRR12 HOXC10 BRCA1 UBQLN4 RPRD2 ELF4 CHD3 CHD4 INO80D HNRNPH3	3.23e-04	1294	72	10	30804502
Pubmed	SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.	PYGL MCM7 RRM1	3.24e-04	64	72	3	26511642
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	GPC1 AP1B1 XPO5 MRPS23 MCM7 CHD3 HNRNPH3	3.65e-04	641	72	7	36057605
Pubmed	Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling.	VCAN TEK	3.78e-04	14	72	2	31319059
Pubmed	The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny.	CHD3 CHD4	3.78e-04	14	72	2	17360773
Pubmed	MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.	CHD3 CHD4	3.78e-04	14	72	2	16428440
Pubmed	Lymphatic vessels interact dynamically with the hair follicle stem cell niche during skin regeneration in vivo.	PKD1 PLXND1	3.78e-04	14	72	2	31475747
Pubmed	Subtype-Specific Genes that Characterize Subpopulations of Callosal Projection Neurons in Mouse Identify Molecularly Homologous Populations in Macaque Cortex.	CITED2 PLXND1	3.78e-04	14	72	2	26874185
Pubmed	Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.	CHD3 CHD4	3.78e-04	14	72	2	20585571
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	5.06e-04	12	51	2	1305
Coexpression	ESC_V6.5_UP_EARLY.V1_UP	NCOA2 DLC1 LPAR4 RPRD2 RYR3 MAST3	6.52e-06	166	72	6	M2770
Coexpression	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	CYP1B1 AGFG1 PYGL NCF4 PLXND1 PGAP6	6.98e-06	168	72	6	M5662
Coexpression	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	CYP1B1 FAT1 VCAN CPEB4 LGR4	1.33e-05	110	72	5	M8831
Coexpression	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN	CYP1B1 MAN2B1 LGR4 PYGL PLXND1 TNS3	1.88e-05	200	72	6	M4612
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	CITED2 AP1B1 CPEB4 CHD3 PLXND1 SCRIB	1.88e-05	200	72	6	M5069
Coexpression	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	AP1B1 ZFP36L2 MCM7 CHD3 CHD4 PLXND1	1.88e-05	200	72	6	M3407
Coexpression	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	COQ8A SYNE1 MCM7 CHD4 PLXND1 MAST3	1.88e-05	200	72	6	M3404
Coexpression	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN	BRAF ZFP36L2 CPEB4 AGFG1 TEK HNRNPH3	1.88e-05	200	72	6	M9923
Coexpression	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	CYP1B1 VCAN AGFG1 PYGL NCF4 PLXND1	1.88e-05	200	72	6	M4966
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	DNAJC13 SLC2A9 BRAF ZFP36L2 AGFG1 MAST3	1.88e-05	200	72	6	M8500
Coexpression	PLASARI_TGFB1_TARGETS_10HR_DN	CYP1B1 HOXC10 LPAR4 GAS2 LGR4 PRKAR2B	7.79e-05	258	72	6	M2446
Coexpression	PLASARI_TGFB1_TARGETS_10HR_DN	CYP1B1 HOXC10 LPAR4 GAS2 LGR4 PRKAR2B	1.02e-04	271	72	6	MM1075
CoexpressionAtlas	DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000	GPC1 CITED2 CYP1B1 HOXC10 DLC1 AFP PI4KB LGR4 PHOSPHO2 CHD4 PLXND1 PGAP6	2.27e-05	837	72	12	gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	4.89e-07	181	72	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	4.89e-07	181	72	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	15-Trachea-Epithelial-Secretory_progenitor\|Trachea / Age, Tissue, Lineage and Cell class	CYP1B1 CTTNBP2 DLC1 COL27A1 VCAN PLXND1	5.92e-07	187	72	6	be9fce9e74b2f170a2067f1b31d802912a578329
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CITED2 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	7.12e-07	193	72	6	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D SYNE1 PLXND1 TEK EDIL3 GRAP	7.34e-07	194	72	6	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	7.79e-07	196	72	6	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	7.79e-07	196	72	6	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	7.79e-07	196	72	6	023477a499a2c190f363cfdbc9d9c646733a6541
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPC1 ZNF385D ADGRG7 DLC1 PKD1 RYR3	7.79e-07	196	72	6	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	7.79e-07	196	72	6	3cb74f1a333a82cac2b459f2f1517e2acf22b5fd
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF385D CYP1B1 DLC1 PLXND1 TEK RYR3	8.51e-07	199	72	6	07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	8.51e-07	199	72	6	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 VCAN EDIL3	8.51e-07	199	72	6	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRR12 BRCA1 MCM7 NCF4 NOS1	5.45e-06	156	72	5	6f8622716bad4e505f241a2a4ef953bf3fc6dbfa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CTTNBP2 SYNE1 EDIL3 TNS3	9.79e-06	176	72	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LPAR4 PLXND1 TEK EDIL3 GRAP	1.06e-05	179	72	5	d24513a404c9b1d37dd47aa1cdb5713b64b88f89
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CTTNBP2 COL27A1 EDIL3 TNS3	1.12e-05	181	72	5	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D DLC1 PLXND1 TEK GRAP	1.18e-05	183	72	5	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D DLC1 PLXND1 TEK GRAP	1.18e-05	183	72	5	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 AFP PRKAR2B MCM7 RRM1	1.18e-05	183	72	5	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRCA1 AFP PRKAR2B MCM7 RRM1	1.25e-05	185	72	5	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DLC1 COL27A1 GAS2 PPP6R2 TNS3	1.25e-05	185	72	5	1d874608aa2062024323512f68889219471b2f00
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 ZNF385D HOXC10 COL27A1 EDIL3	1.28e-05	186	72	5	80a0a42ca8585cdb1dda57a18c254316a126ee64
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DLC1 COL27A1 GAS2 LGR4 TNS3	1.31e-05	187	72	5	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CITED2 CTTNBP2 SYNE1 VCAN EDIL3	1.31e-05	187	72	5	9225caf66e06ebe57e90d677122acb6498607f36
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 FAT1 LPAR4 LGR4 EDIL3	1.35e-05	188	72	5	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	GPC1 DLC1 RCAN1 VCAN TNS3	1.38e-05	189	72	5	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D PLXND1 TEK EDIL3 RYR3	1.42e-05	190	72	5	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	GPC1 DLC1 RCAN1 VCAN TNS3	1.42e-05	190	72	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LPAR4 PLXND1 TEK EDIL3 GRAP	1.45e-05	191	72	5	44c596984c6196f6014e0e405dbe5560841e54ff
ToppCell	E16.5-samps-Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LPAR4 PLXND1 TEK EDIL3 GRAP	1.45e-05	191	72	5	e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	GPC1 CITED2 CYP1B1 FAT1 TNS3	1.45e-05	191	72	5	78ad7c555409ce1391bce406bc0f3ef575329ece
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF385D CYP1B1 PLXND1 TEK RYR3	1.49e-05	192	72	5	eafead22bba48ac5ee568faa8946c444445c1034
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D PLXND1 TEK EDIL3 RYR3	1.49e-05	192	72	5	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega\|bone_marrow / Manually curated celltypes from each tissue	ZNF385D DLC1 PRKAR2B TEK RYR3	1.49e-05	192	72	5	cbc304c704e8524eee24a1619d0fbb2cf96c4976
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 PLXND1 TEK EDIL3 RYR3	1.49e-05	192	72	5	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	11.5-Airway-Mesenchymal-Cartilage\|Airway / Age, Tissue, Lineage and Cell class	GPC1 LPAR4 COL27A1 PYGL EDIL3	1.53e-05	193	72	5	d4779d92a4dd4b8b656383e6f4fce76d3bd70931
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 PLXND1 TEK EDIL3 GRAP	1.53e-05	193	72	5	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF385D DLC1 PLXND1 TEK RYR3	1.53e-05	193	72	5	c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D DLC1 PLXND1 TEK GRAP	1.53e-05	193	72	5	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D PLXND1 TEK EDIL3 RYR3	1.53e-05	193	72	5	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 EDIL3	1.57e-05	194	72	5	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	CYP1B1 SYNE1 AGFG1 PYGL NCF4	1.61e-05	195	72	5	22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	SLC2A9 RCAN1 AGFG1 NCF4 TNS3	1.61e-05	195	72	5	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF385D CYP1B1 DLC1 TEK NOS1	1.61e-05	195	72	5	53b83e16b350100b1d5791a9c42bd98e37cbc0af
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	CYP1B1 DNAJC13 VCAN AGFG1 PYGL	1.65e-05	196	72	5	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|COVID-19_Mild / Disease condition and Cell class	CYP1B1 DNAJC13 VCAN AGFG1 PYGL	1.65e-05	196	72	5	f245e929a286cb097130572e1027b4f01be8b04d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 CTTNBP2 SYNE1 EDIL3	1.65e-05	196	72	5	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF385D CYP1B1 PLXND1 TEK RYR3	1.69e-05	197	72	5	87eda06344498dc66cac292cf89746dc90b5cf67
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D DLC1 PLXND1 TEK GRAP	1.69e-05	197	72	5	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	severe_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	CYP1B1 VCAN AGFG1 PYGL NCF4	1.69e-05	197	72	5	cdffd49db7374d223ded46d636cd4be12d464ea4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 DLC1 SYNE1 COL27A1 TNS3	1.69e-05	197	72	5	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 DLC1 SYNE1 COL27A1 TNS3	1.69e-05	197	72	5	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPC1 ZNF385D VCAN EDIL3 RYR3	1.69e-05	197	72	5	467e7cbf511d3bcc701923603032aaf0bba2736d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D DLC1 PLXND1 TEK GRAP	1.69e-05	197	72	5	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GPC1 COL27A1 VCAN CHD3 EDIL3	1.73e-05	198	72	5	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GPC1 COL27A1 VCAN CHD3 EDIL3	1.73e-05	198	72	5	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	VCAN CPEB4 AGFG1 PYGL PLXND1	1.73e-05	198	72	5	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF385D CYP1B1 DLC1 TEK NOS1	1.73e-05	198	72	5	71ee440b1ac566db63d0b415c50a0ad064d14f15
ToppCell	COVID-19_Mild-Classical_Monocyte\|COVID-19_Mild / Disease condition and Cell class	CYP1B1 VCAN AGFG1 PYGL PLXND1	1.73e-05	198	72	5	30ada3de865b6fb2b14196a1cbfd4740c6a57ce3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 VCAN TEK EDIL3 NOS1	1.77e-05	199	72	5	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CPEB4 AGFG1 PYGL NCF4	1.77e-05	199	72	5	b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 VCAN TEK EDIL3 NOS1	1.77e-05	199	72	5	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF385D SYNE1 COL27A1 PYGL EDIL3	1.81e-05	200	72	5	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF385D CYP1B1 DLC1 TEK NOS1	1.81e-05	200	72	5	84e145619a500530f42ed0fe72468ae95f4cbf1e
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP1B1 DLC1 SYNE1 VCAN EDIL3	1.81e-05	200	72	5	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF385D SYNE1 COL27A1 PYGL EDIL3	1.81e-05	200	72	5	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	CITED2 ZNF385D VCAN PRKAR2B CHD3	1.81e-05	200	72	5	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF385D DLC1 SYNE1 VCAN EDIL3	1.81e-05	200	72	5	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	severe-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CYP1B1 VCAN AGFG1 PYGL NCF4	1.81e-05	200	72	5	f46689940fdea500ce2457eec412dd2c46705819
ToppCell	medial-Endothelial-Vein-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF385D CYP1B1 DLC1 TEK NOS1	1.81e-05	200	72	5	3f689029f5bc7db0af50a405f1e252aeec529077
ToppCell	3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF385D CYP1B1 DLC1 PLXND1 TEK	1.81e-05	200	72	5	cee07d9370656e1c428a7a9e9fbd175129901374
ToppCell	distal-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF385D CYP1B1 DLC1 TEK NOS1	1.81e-05	200	72	5	2785225956d2422acab90e99b7debe3709cf3308
ToppCell	medial-Endothelial-Vein\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF385D CYP1B1 DLC1 TEK NOS1	1.81e-05	200	72	5	1163e5f6dfb304c94bf8885629350454f4b6bee8
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CPEB4 AGFG1 PYGL NCF4	1.81e-05	200	72	5	808571d74bb5c4d765ff13fc9393f88020d4e90d
ToppCell	medial-2-Endothelial-Vein\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF385D CYP1B1 DLC1 TEK NOS1	1.81e-05	200	72	5	49da4e3ff10262a492c2cf566a7f2e35e418bfda
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP23 COQ8A MRPS23 PGAP6	8.28e-05	142	72	4	0a87c0d74e281da5dc4f59e09a5e99c62b1ea801
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRACR2A SYNE1 KCNS2 TEK	9.22e-05	146	72	4	281144e293e8c93a425c2606d2188cb2838e667f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 SYNE1 GAS2 EDIL3	1.02e-04	150	72	4	8645b9c7f9511ed6cc9afe04440c2873a3094150
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT1 CRACR2A VCAN NOS1	1.08e-04	152	72	4	fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D PLXND1 TEK EDIL3	1.16e-04	155	72	4	babcb9e548f04ace8157d506d27c5941c692c491
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CTTNBP2 SYNE1 VCAN	1.19e-04	156	72	4	dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CTTNBP2 SYNE1 VCAN	1.19e-04	156	72	4	abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIP MCM7 RRM1 NOS1	1.31e-04	160	72	4	ec81814f3a475ba9bc049cb793bf93bc0b650d37
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LGR4 PHOSPHO2 NOS1 RYR3	1.38e-04	162	72	4	373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 PRKAR2B PYGL PGAP6	1.41e-04	163	72	4	57f02f2b9ce940a2962bb57cd8d02eb67b6f44a3
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 PRKAR2B PYGL PGAP6	1.41e-04	163	72	4	155ac52a34e0d55545aab8a3e4162fc4c387e697
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRCA1 PRKAR2B PYGL PGAP6	1.41e-04	163	72	4	c132fb5b56186a10d33ae5ce17b2a7e670d52f79
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 CPEB4 LGR4 EDIL3	1.44e-04	164	72	4	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D PLXND1 TEK GRAP	1.48e-04	165	72	4	6a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP1B1 RCAN1 TEK NOS1	1.51e-04	166	72	4	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT1 CTTNBP2 COL27A1 EDIL3	1.58e-04	168	72	4	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VCAN PRKAR2B KCNS2 EDIL3	1.62e-04	169	72	4	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXC10 VCAN EDIL3 SLITRK1	1.66e-04	170	72	4	10e0912dd0beab5d0bbe2bd49e477b5962687925
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 SYNE1 GAS2 PYGL	1.73e-04	172	72	4	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	CTTNBP2 SYNE1 VCAN EDIL3	1.73e-04	172	72	4	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 SYNE1 GAS2 PYGL	1.73e-04	172	72	4	553701349444eb366df3c11f54bb093434f153c6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF385D SYNE1 TEK EDIL3	1.73e-04	172	72	4	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM7 PHOSPHO2 SCRIB TEK	1.77e-04	173	72	4	12f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	DHRS12 XPO5 MRPS23 ALG11	1.81e-04	174	72	4	b5a7a612a515736cf3489afd0f6ad2054d54526f
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A	NCOA2 DHRS12 RCAN1 LGR4 ELF4 PLXND1 MAST3	2.61e-06	193	72	7	3103_DN
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	CYP1B1 DLC1 ZFP36L2 SYNE1 GAS2 ELF4 MAST3	2.99e-06	197	72	7	2822_DN
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A	BRCA1 PI4KB RPRD2 ELF4 CHD3 NOS1 MAST3	3.19e-06	199	72	7	1557_DN
Drug	cyanoacetic acid	SYNE1 MIP	9.86e-06	2	72	2	CID000009740
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4 TNS3	1.59e-05	169	72	6	5231_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4 TNS3	1.76e-05	172	72	6	1072_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4 TNS3	2.01e-05	176	72	6	6932_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	CYP1B1 ZFP36L2 PI4KB MCM7 ELF4 RRM1	2.58e-05	184	72	6	6916_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	CYP1B1 BRCA1 BRAF ZFP36L2 ELF4 PPP6R2	3.18e-05	191	72	6	5210_DN
Drug	17-AAG; Down 200; 1uM; ssMCF7; HG-U133A	CYP1B1 AP1B1 ELF4 PLXND1 PPP6R2 MAST3	3.18e-05	191	72	6	521_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	CITED2 CYP1B1 DLC1 ELF4 PPP6R2 MAST3	3.47e-05	194	72	6	7137_DN
Drug	Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	BRCA1 AP1B1 VCAN PLXND1 EDIL3 MAST3	3.57e-05	195	72	6	5070_DN
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 RCAN1 ZFP36L2 NOS1 MAST3	3.57e-05	195	72	6	5028_UP
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	DLC1 ZFP36L2 SYNE1 PI4KB GAS2 NCF4	3.67e-05	196	72	6	5279_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	GPC1 CYP1B1 ZFP36L2 SYNE1 VCAN INO80D	3.67e-05	196	72	6	6619_DN
Drug	Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A	RCAN1 ZFP36L2 VCAN LGR4 ELF4 PGAP6	3.67e-05	196	72	6	6344_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	CYP1B1 HOXC10 RCAN1 ZFP36L2 ELF4 INO80D	3.67e-05	196	72	6	3541_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A	NCOA2 DLC1 ZFP36L2 SYNE1 NOS1 INO80D	3.78e-05	197	72	6	3145_DN
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A	AP1B1 ZFP36L2 RPRD2 ELF4 CHD3 NOS1	3.89e-05	198	72	6	4805_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	DLC1 ZFP36L2 CHD3 CHD4 NOS1 INO80D	4.11e-05	200	72	6	3827_DN
Drug	FdUrd-C8	AFP PYGL	5.89e-05	4	72	2	CID000094262
Drug	riparin	AGFG1 NOS1	5.89e-05	4	72	2	CID000182537
Drug	dioxybenzone	NCOA2 AFP	9.80e-05	5	72	2	ctd:C004839
Drug	reazide	SYNE1 MIP	9.80e-05	5	72	2	CID000008820
Drug	NSC 674495	CYP1B1 BRCA1	1.47e-04	6	72	2	ctd:C122062
Drug	4-hydroxychalcone	CYP1B1 AFP	1.47e-04	6	72	2	ctd:C451019
Drug	vinylidene chloride	FAT1 DLC1 BRCA1 COQ8A AFP COL27A1 GAS2 AGFG1 LGR4 PYGL RPRD2 NCF4 RRM1 TEK	1.85e-04	1475	72	14	ctd:C029297
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 ELF4 TNS3	1.88e-04	167	72	5	5217_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 TNS3	1.93e-04	168	72	5	3868_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.04e-04	170	72	5	1050_DN
Drug	benzo(a)pyrene-DNA adduct	CYP1B1 BRCA1	2.05e-04	7	72	2	ctd:C056612
Drug	AC1NURG3	CYP1B1 ELF4	2.05e-04	7	72	2	CID005459347
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.10e-04	171	72	5	1000_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.28e-04	174	72	5	5945_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 ELF4 TNS3	2.28e-04	174	72	5	1659_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 ELF4 TNS3	2.28e-04	174	72	5	5580_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 VCAN ELF4	2.34e-04	175	72	5	1161_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.34e-04	175	72	5	7236_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.34e-04	175	72	5	1058_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 BRAF ZFP36L2 RPRD2	2.34e-04	175	72	5	6891_DN
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 VCAN ELF4	2.40e-04	176	72	5	6179_DN
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; HL60; HT_HG-U133A	DLC1 RCAN1 GAS2 PRKAR2B TEK	2.40e-04	176	72	5	3102_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.46e-04	177	72	5	6434_DN
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CYP1B1 HOXC10 AGFG1 ELF4 TNS3	2.46e-04	177	72	5	841_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.46e-04	177	72	5	6551_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 TNS3	2.46e-04	177	72	5	5308_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	CYP1B1 ZFP36L2 VCAN ELF4 NCF4	2.53e-04	178	72	5	6193_DN
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A	CITED2 CYP1B1 ZFP36L2 ELF4 TNS3	2.53e-04	178	72	5	1736_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.53e-04	178	72	5	992_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.53e-04	178	72	5	6276_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	NCOA2 CYP1B1 VCAN RPRD2 ELF4	2.60e-04	179	72	5	1175_DN
Drug	DIBAH	SYNE1 PYGL	2.73e-04	8	72	2	CID000014487
Drug	6-methoxypurine	AFP PYGL	2.73e-04	8	72	2	CID000070632
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 CYP1B1 ZFP36L2 RPRD2 ELF4	2.73e-04	181	72	5	6951_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CYP1B1 HOXC10 DLC1 BRCA1 ZFP36L2	3.10e-04	186	72	5	831_DN
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	DLC1 MCM7 ELF4 PLXND1 PPP6R2	3.17e-04	187	72	5	1656_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GPC1 CYP1B1 COQ8A ZFP36L2 ELF4	3.25e-04	188	72	5	986_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	DLC1 ZFP36L2 VCAN LGR4 PLXND1	3.25e-04	188	72	5	6195_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	LPAR4 ZFP36L2 VCAN LGR4 PLXND1	3.33e-04	189	72	5	1168_DN
Drug	15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A	CITED2 ZFP36L2 VCAN LGR4 PLXND1	3.42e-04	190	72	5	1172_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	NCOA2 HOXC10 AGFG1 CHD4 EDIL3	3.42e-04	190	72	5	4322_DN
Drug	3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A	CYP1B1 DLC1 SLC2A9 VCAN EDIL3	3.58e-04	192	72	5	5624_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	BRAF COQ8A ELF4 PLXND1 TNS3	3.58e-04	192	72	5	1059_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	NCOA2 CYP1B1 AGFG1 CHD3 EDIL3	3.58e-04	192	72	5	5058_DN
Drug	2hfp	AGFG1 HNRNPH3 RYR3	3.66e-04	44	72	3	CID009549238
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	DNAJC13 BRCA1 ZFP36L2 PI4KB PPP6R2	3.67e-04	193	72	5	2114_DN
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; PC3; HG-U133A	CYP1B1 AP1B1 RCAN1 MCM7 RPRD2	3.76e-04	194	72	5	1954_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	SLC2A9 ZFP36L2 VCAN CHD3 PPP6R2	3.76e-04	194	72	5	1856_DN
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	CYP1B1 HOXC10 LPAR4 ZFP36L2 INO80D	3.76e-04	194	72	5	6667_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	ZNF385D CYP1B1 BRCA1 PI4KB PPP6R2	3.76e-04	194	72	5	1814_DN
Drug	Fosfosal [6064-83-1]; Down 200; 18.4uM; PC3; HT_HG-U133A	NCOA2 HOXC10 ZFP36L2 SYNE1 PLXND1	3.76e-04	194	72	5	4239_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	NCOA2 RCAN1 VCAN RPRD2 PGAP6	3.85e-04	195	72	5	4644_DN
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; HL60; HT_HG-U133A	CITED2 CYP1B1 RCAN1 LGR4 INO80D	3.85e-04	195	72	5	2509_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A	NCOA2 CYP1B1 DLC1 SLC2A9 MAST3	3.85e-04	195	72	5	3108_DN
Drug	Tyloxapol [25301-02-4]; Down 200; 4uM; PC3; HT_HG-U133A	ZNF385D RCAN1 ZFP36L2 PI4KB ELF4	3.85e-04	195	72	5	4611_DN
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A	MAN2B1 LPAR4 ZFP36L2 SYNE1 PLXND1	3.85e-04	195	72	5	1290_DN
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A	NCOA2 RCAN1 ZFP36L2 AGFG1 INO80D	3.85e-04	195	72	5	3237_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NCOA2 DHRS12 MAN2B1 PI4KB PPP6R2	3.85e-04	195	72	5	7172_DN
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	ZNF385D CYP1B1 SLC2A9 ZFP36L2 INO80D	3.94e-04	196	72	5	5757_UP
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	CYP1B1 HOXC10 LPAR4 ZFP36L2 VCAN	3.94e-04	196	72	5	4196_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	GPC1 ZFP36L2 CHD3 PLXND1 PPP6R2	3.94e-04	196	72	5	3416_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A	NCOA2 HOXC10 RCAN1 NOS1 INO80D	3.94e-04	196	72	5	1524_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A	GPC1 NCOA2 BRAF CHD3 MAST3	3.94e-04	196	72	5	5751_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	BRCA1 CHD3 PLXND1 PPP6R2 EDIL3	3.94e-04	196	72	5	5079_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A	DHRS12 ELF4 PPP6R2 PGAP6 HNRNPH3	3.94e-04	196	72	5	1968_UP
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; HL60; HG-U133A	RCAN1 LGR4 RPRD2 INO80D HNRNPH3	3.94e-04	196	72	5	1964_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	HOXC10 CHD3 PPP6R2 INO80D MAST3	3.94e-04	196	72	5	7054_UP
Drug	Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A	GPC1 ZNF385D SLC2A9 SYNE1 NOS1	3.94e-04	196	72	5	2098_UP
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	NCOA2 SYNE1 ELF4 CHD3 PLXND1	3.94e-04	196	72	5	7377_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	DLC1 SLC2A9 BRAF RCAN1 NCF4	3.94e-04	196	72	5	3965_DN
Drug	Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A	GPC1 HOXC10 BRAF EDIL3 NOS1	3.94e-04	196	72	5	6344_UP
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CYP1B1 RCAN1 SYNE1 GAS2 HNRNPH3	3.94e-04	196	72	5	2818_DN
Drug	deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A	CYP1B1 ZFP36L2 MIP ELF4 TEK	3.94e-04	196	72	5	485_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; HL60; HT_HG-U133A	DHRS12 LPAR4 AP1B1 ZFP36L2 VCAN	3.94e-04	196	72	5	3085_DN
Drug	0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A	BRCA1 PI4KB MCM7 RRM1 HNRNPH3	3.94e-04	196	72	5	6902_DN
Drug	Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	NCOA2 RCAN1 ZFP36L2 PLXND1 MAST3	3.94e-04	196	72	5	5060_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	GPC1 CYP1B1 ZFP36L2 VCAN EDIL3	3.94e-04	196	72	5	5072_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A	CYP1B1 LPAR4 RCAN1 ZFP36L2 VCAN	4.03e-04	197	72	5	4207_DN
Drug	Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A	HOXC10 LPAR4 RCAN1 ZFP36L2 VCAN	4.03e-04	197	72	5	6514_UP
Drug	Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A	GPC1 NCOA2 BRAF SYNE1 CHD3	4.03e-04	197	72	5	4608_DN
Disease	colorectal cancer (is_implicated_in)	FAT1 DLC1 BRCA1 BRAF XPO5 CHD4	3.41e-07	121	67	6	DOID:9256 (is_implicated_in)
Disease	Glaucoma 3, primary infantile, B	CYP1B1 TEK	1.52e-05	3	67	2	cv:C1832977
Disease	GLAUCOMA 3, PRIMARY INFANTILE, B	CYP1B1 TEK	1.52e-05	3	67	2	600975
Disease	GLAUCOMA 3, PRIMARY INFANTILE, B	CYP1B1 TEK	1.52e-05	3	67	2	C1832977
Disease	Colorectal Neoplasms	CYP1B1 FAT1 DLC1 BRAF ZFP36L2 SYNE1	4.00e-05	277	67	6	C0009404
Disease	Hydrophthalmos	CYP1B1 TEK	5.06e-05	5	67	2	C0020302
Disease	childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement	CYP1B1 PYGL	7.57e-05	6	67	2	EFO_0004847, EFO_0008361, MONDO_0005405
Disease	Adenoid Cystic Carcinoma	FAT1 BRCA1 VCAN GAS2	8.08e-05	100	67	4	C0010606
Disease	Malignant neoplasm of salivary gland	FAT1 VCAN GAS2	1.48e-04	45	67	3	C0220636
Disease	Salivary Gland Neoplasms	FAT1 VCAN GAS2	1.69e-04	47	67	3	C0036095
Disease	urate measurement	DNAJC13 SLC2A9 USP38 COQ8A CPEB4 UBQLN4 LGR4 CHD3 MAST3	1.85e-04	895	67	9	EFO_0004531
Disease	Colorectal Carcinoma	ZNF385D CYP1B1 FAT1 DLC1 BRAF ZFP36L2 SYNE1 AKAP3	1.87e-04	702	67	8	C0009402
Disease	Malignant Neoplasms	CITED2 DLC1 BRCA1 BRAF	2.10e-04	128	67	4	C0006826
Disease	Breast Carcinoma	NCOA2 CYP1B1 BRCA1 BRAF AFP SYNE1 MRPS23	2.18e-04	538	67	7	C0678222
Disease	ovarian neoplasm	CYP1B1 DLC1 BRCA1 BRAF	2.50e-04	134	67	4	C0919267
Disease	Malignant neoplasm of ovary	CYP1B1 DLC1 BRCA1 BRAF	2.72e-04	137	67	4	C1140680
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 FAT1 BRCA1 XPO5	2.87e-04	139	67	4	DOID:3908 (is_implicated_in)
Disease	intracranial aneurysm (is_implicated_in)	VCAN PKD1	3.30e-04	12	67	2	DOID:10941 (is_implicated_in)
Disease	Prostatic Neoplasms	NCOA2 CYP1B1 BRCA1 BRAF ZFP36L2 RPRD2 CHD3	4.91e-04	616	67	7	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 CYP1B1 BRCA1 BRAF ZFP36L2 RPRD2 CHD3	4.91e-04	616	67	7	C0376358
Disease	Benign Neoplasm	CITED2 DLC1 BRCA1	5.05e-04	68	67	3	C0086692
Disease	Neoplasms	CITED2 DLC1 BRCA1	5.05e-04	68	67	3	C0027651
Disease	cancer biomarker measurement	AFP PPIP5K1	5.23e-04	15	67	2	EFO_0005127
Disease	Replication Error Phenotype	BRAF XPO5	5.23e-04	15	67	2	C1721098
Disease	Microsatellite Instability	BRAF XPO5	5.23e-04	15	67	2	C0920269
Disease	Malignant neoplasm of breast	GPC1 NCOA2 CYP1B1 BRCA1 BRAF AFP SYNE1 MRPS23 TEK	6.96e-04	1074	67	9	C0006142
Disease	Adrenocortical carcinoma	BRAF RRM1	7.59e-04	18	67	2	C0206686
Disease	Pancreatic carcinoma	BRCA1 BRAF	8.47e-04	19	67	2	C0235974
Disease	cortical thickness	NCOA2 CTTNBP2 DLC1 XPO5 VCAN CPEB4 PKD1 LGR4 PLXND1	8.96e-04	1113	67	9	EFO_0004840
Disease	Adenocarcinoma of prostate	BRCA1 BRAF	9.40e-04	20	67	2	C0007112
Disease	prostate adenocarcinoma (is_implicated_in)	NCOA2 BRAF	9.40e-04	20	67	2	DOID:2526 (is_implicated_in)
Disease	Liver carcinoma	ADGRG7 BRAF RCAN1 AFP PYGL RRM1	1.03e-03	507	67	6	C2239176
Disease	Mammary Carcinoma, Human	NCOA2 CYP1B1 BRCA1 AFP SYNE1 MRPS23	1.23e-03	525	67	6	C4704874
Disease	Mammary Neoplasms, Human	NCOA2 CYP1B1 BRCA1 AFP SYNE1 MRPS23	1.23e-03	525	67	6	C1257931
Disease	Mammary Neoplasms	NCOA2 CYP1B1 BRCA1 AFP SYNE1 MRPS23	1.25e-03	527	67	6	C1458155
Disease	nephrotic syndrome (implicated_via_orthology)	FAT1 COQ8A	1.36e-03	24	67	2	DOID:1184 (implicated_via_orthology)
Disease	white matter integrity, age at assessment	VCAN ICA1L	1.59e-03	26	67	2	EFO_0004641, EFO_0008007
Disease	brain ischemia (biomarker_via_orthology)	CITED2 TEK NOS1	1.64e-03	102	67	3	DOID:2316 (biomarker_via_orthology)
Disease	Colorectal cancer	DLC1 BRAF	1.72e-03	27	67	2	cv:C0346629
Disease	COLORECTAL CANCER	DLC1 BRAF	1.72e-03	27	67	2	114500
Disease	Neoplasm of the large intestine	DLC1 BRAF	1.72e-03	27	67	2	cv:C0009404
Disease	Sezary Syndrome	BRAF CHD3	1.72e-03	27	67	2	C0036920
Disease	lung small cell carcinoma (is_implicated_in)	FAT1 XPO5	1.85e-03	28	67	2	DOID:5409 (is_implicated_in)
Disease	stimulant use measurement	NCOA2 DLC1	1.85e-03	28	67	2	EFO_0600076
Disease	hepatocellular carcinoma (biomarker_via_orthology)	AFP MCM7 TEK	1.93e-03	108	67	3	DOID:684 (biomarker_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of ovary	BRCA1 BRAF	1.98e-03	29	67	2	C0496920
Disease	Ovarian Carcinoma	BRCA1 BRAF	2.12e-03	30	67	2	C0029925
Disease	serum albumin measurement	PRR12 DNAJC13 AFP CPEB4 MIP PRKAR2B	2.25e-03	592	67	6	EFO_0004535

Protein segments in the cluster

Peptide	Gene	Start	Entry
LDTAAAVNLFPNFNA	ZNF385D	41	Q9H6B1
GFNNAAFITRNPFLS	ALG11	216	Q2TAA5
PSLNRAGFQTEDFSL	BRAF	731	P15056
RGQFESVAPSQNFSD	VCAN	1431	P13611
QFDFSAQDPSQLSFR	GRAP	166	Q13588
FFFSQNNPSQEDAGE	CRACR2A	116	Q9BSW2
DFAIQFNRNSFGLAP	AP1B1	761	Q10567
NFSSENAVGPSNVRF	ADGRG7	261	Q96K78
ARSFAPAILTGNFTN	MIP	186	P30301
INFSNPFSAADARLQ	RCAN1	111	P53805
RLAQGNPQQGFFSSF	ATP23	31	Q9Y6H3
SDVNDNAPVFSRGNY	FAT1	3431	Q14517
ASFPLNASFQDSQVA	ELF4	461	Q99607
NDSERTLQATFPGAF	GPC1	116	P35052
FIDFQFQDSNSSLRP	LPAR4	6	Q99677
SNASAPVDFFINGRA	PLXND1	1131	Q9Y4D7
NDASKFDGQPLGNFR	KCNS2	156	Q9ULS6
AAPRAEALFDFTGNS	NCF4	171	Q15080
GLPFRATENDIANFF	HNRNPH3	201	P31942
DNPLSFVGNSAFHNL	LGR4	281	Q9BXB1
PSSFNLALSQAFRGS	GOLGA6L2	136	Q8N9W4
VNAASPFLGFNTSLN	PGAP6	421	Q9HCN3
VFTNPAAFNSNGHLT	PHOSPHO2	121	Q8TCD6
SRGFTPAQFQAALDE	MCM7	686	P33993
DNFESAGPLANVRFS	NOS1	871	P29475
RQSFAPFSNPGNAEE	BRCA1	866	P38398
FRGNIDNNTPYANSF	EDIL3	271	O43854
QAARFRFQGNANDPD	CTTNBP2	446	Q8WZ74
FSANNPFKGSAAAVA	CHD3	196	Q12873
RFNAPGAQQFCFLLS	CHD3	1121	Q12873
ANGRLFANPRDSFSA	COQ8A	141	Q8NI60
ALSSAAAAQPSGRFF	DHRS12	266	A0PJE2
SQDSGRPFTFQSDLA	COL27A1	251	Q8IZC6
PNGNFADAVFRFNAN	DNAJC13	366	O75165
GANDFEAPFEQRASL	HOXC10	166	Q9NYD6
NESDQASGAYIFRPN	MAN2B1	651	O00754
SPRNFSAASALNFPF	MAST3	61	O60307
QLPQFSAAFGHQLSS	INO80D	971	Q53TQ3
FFQQSQRPAAFIIAG	SLC2A9	441	Q9NRM0
ADAGAFNAPVINRFT	PRKAR2B	96	P31323
PAASANNGALLFQNF	CPEB4	196	Q17RY0
ALVQQGSAFADRPAF	CYP1B1	106	Q16678
REFGAPQFSNSENVA	ICA1L	316	Q8NDH6
RFNAPGAQQFCFLLS	CHD4	1111	Q14839
APQFQESVGSFRSNS	RPRD2	1171	Q5VT52
GAFPNELSLQQAFSD	PPP6R2	551	O75170
NRFLGDRDFNQFSSG	AFP	331	P02771
QPAARAAQAFFPAAE	SCRIB	71	C0HLS1
AAQAFFPAAELAQAG	SCRIB	76	C0HLS1
FPDAGTFSIRLNASN	PKD1	1856	P98161
SAPSGSFFARDNTAN	GAS2	101	O43903
GQRAFDLFNPNFKST	MRPS23	81	Q9Y3D9
GFPSFANSVQNFKRE	SYNE1	301	Q8NF91
AAAEQSSPQLYNFSG	PRR12	256	Q9ULL5
RADASSTPSFQQAFA	TNS3	911	Q68CZ2
QRAGSFSTVPNYDND	PI4KB	441	Q9UBF8
LEGFDPFNQSTFNNV	DLC1	776	Q96QB1
SLGFQHAAFEAPNTQ	AKAP3	471	O75969
PAPQSTATANFANFA	AGFG1	211	P52594
ALAPAARFNNSQFMG	CITED2	86	Q99967
ASFASQNRQPFGSSP	NCOA2	1046	Q15596
ESTNAFQAFLARSAP	TEX22	121	C9J3V5
HGNSLTRLFPNEFAN	SLITRK1	66	Q96PX8
FNAGTNRPQLSSCFL	RRM1	206	P23921
ALFSQFVSGNNRTAA	RYR3	416	Q15413
DFNAFFNSSRAQQGE	XPO5	431	Q9HAV4
DIFAENNIGSSNPAF	TEK	711	Q02763
QAASASCSFRPNGFD	USP38	1001	Q8NB14
ASCANNAFAFGPELS	ZFP36L2	356	P47974
SGEDAGNNFFLQRSS	NAE1	66	Q13564
SARAPNDFNLRDFNV	PYGL	246	P06737
AAREQFGNNPFSSLA	UBQLN4	296	Q9NRR5
FSNASRGFQNPETLA	UPK3B	131	Q9BT76
QFGFSDQPSLNSHVA	PPIP5K1	1191	Q6PFW1